Congress:
ECR25
Poster Number:
C-27870
Type:
Poster: EPOS Radiologist (scientific)
Authorblock:
A. Iozzelli, A. Cipriani, L. Costarelli; Macerata/IT
Disclosures:
Andrea Iozzelli:
Nothing to disclose
Antonio Cipriani:
Nothing to disclose
Leonardo Costarelli:
Nothing to disclose
Keywords:
Breast, Contrast agents, Oncology, MR, Biopsy, Cancer
In our small cohort of consecutive patients, breast MRI with the intravenous administration of gadopiclenol showed a strong enhancement of lesions and veins in all cases, proving to be clinically safe and providing images of optimum quality for the detection and characterization of breast abnormalities. Further studies, including a wider cohort of patients and comparison with other gadolinium-based contrast agents, should be conducted to obtain more robust results.